{"database": "lobbying", "table": "lobbying_filings_raw", "rows": [["0ae8782a-e4e9-4bc3-bcdd-ab34c71ec19d", "Q1", 41454, "WILLIAMS AND JENSEN, PLLC", 151146, "GENENTECH INC", 2015, "first_quarter", "2015-04-13T14:38:38.767000-04:00", 40000.0, 0, 0, 0, "{\"url\": \"https://lda.senate.gov/api/v1/filings/0ae8782a-e4e9-4bc3-bcdd-ab34c71ec19d/\", \"filing_uuid\": \"0ae8782a-e4e9-4bc3-bcdd-ab34c71ec19d\", \"filing_type\": \"Q1\", \"filing_type_display\": \"1st Quarter - Report\", \"filing_year\": 2015, \"filing_period\": \"first_quarter\", \"filing_period_display\": \"1st Quarter (Jan 1 - Mar 31)\", \"filing_document_url\": \"https://lda.senate.gov/filings/public/filing/0ae8782a-e4e9-4bc3-bcdd-ab34c71ec19d/print/\", \"filing_document_content_type\": \"text/html\", \"income\": \"40000.00\", \"expenses\": null, \"expenses_method\": null, \"expenses_method_display\": null, \"posted_by_name\": \"TJ Hartten\", \"dt_posted\": \"2015-04-13T14:38:38.767000-04:00\", \"termination_date\": null, \"registrant_country\": \"United States of America\", \"registrant_ppb_country\": null, \"registrant_address_1\": \"701 8th Street, NW\", \"registrant_address_2\": null, \"registrant_different_address\": false, \"registrant_city\": \"Washington\", \"registrant_state\": \"DC\", \"registrant_zip\": \"20001\", \"registrant\": {\"id\": 41454, \"url\": \"https://lda.senate.gov/api/v1/registrants/41454/\", \"house_registrant_id\": 30771, \"name\": \"WILLIAMS AND JENSEN, PLLC\", \"description\": \"Lobbying Law Firm\", \"address_1\": \"1201 Pennsylvania Avenue, NW\", \"address_2\": \"Suite 800\", \"address_3\": null, \"address_4\": null, \"city\": \"Washington\", \"state\": \"DC\", \"state_display\": \"District of Columbia\", \"zip\": \"20004\", \"country\": \"US\", \"country_display\": \"United States of America\", \"ppb_country\": \"US\", \"ppb_country_display\": \"United States of America\", \"contact_name\": \"ISABELLA QUINN\", \"contact_telephone\": \"+1 202-659-8201\", \"dt_updated\": \"2026-01-30T10:10:58.206597-05:00\"}, \"client\": {\"id\": 151146, \"url\": \"https://lda.senate.gov/api/v1/clients/151146/\", \"client_id\": 393, \"name\": \"GENENTECH INC\", \"general_description\": null, \"client_government_entity\": false, \"client_self_select\": null, \"state\": \"DC\", \"state_display\": \"District of Columbia\", \"country\": \"US\", \"country_display\": \"United States of America\", \"ppb_state\": null, \"ppb_state_display\": null, \"ppb_country\": \"US\", \"ppb_country_display\": \"United States of America\", \"effective_date\": \"2007-02-12\"}, \"lobbying_activities\": [{\"general_issue_code\": \"MMM\", \"general_issue_code_display\": \"Medicare/Medicaid\", \"description\": \"Payment policies for prescription drugs.\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 37173, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"KARINA\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"LYNCH\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 18077, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"GEORGE\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"OLSEN\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 61426, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"CHERYL\", \"nickname\": null, \"middle_name\": \"LYNN\", \"last_name\": \"JAEGER\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": \"Shared employee, Ofc of the Speaker & Ofc of VA 7; Sr Policy Adv, Majority Leader, Rep Eric Cantor; Sr Policy Adv, Republican Whip, Rep Eric Cantor; Sr Policy Adv, Majority Whip, Rep. Roy Blunt; Prof Staff House Committee on E&C; Sr LA to Rep C Cox\", \"new\": true}], \"government_entities\": [{\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}, {\"general_issue_code\": \"TAX\", \"general_issue_code_display\": \"Taxation/Internal Revenue Code\", \"description\": \"General tax issues.\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 43332, \"prefix\": \"mr\", \"prefix_display\": \"MR.\", \"first_name\": \"CHRISTOPHER\", \"nickname\": null, \"middle_name\": \"W\", \"last_name\": \"HATCHER\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 37173, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"KARINA\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"LYNCH\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}, {\"general_issue_code\": \"HCR\", \"general_issue_code_display\": \"Health Issues\", \"description\": \"21st Century Cures Initiative (House Energy and Commerce Committee) and Innovation for Healthier Americans (Senate HELP Committee); Potential pharmaceutical provisions in House Budget Resolution (H. Con. Res. 27) and Senate Budget Resolution (S. Con. Res. 11 ); Possible drug provisions in H.R. 2, the Medicare Access and CHIP Reauthorization Act; issues concerning clinical trials; issues concerning drug compounding; Implementation of Patient Protection and Affordable Care Act; Drug pricing under 340B program.\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 37173, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"KARINA\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"LYNCH\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 18077, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"GEORGE\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"OLSEN\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 65303, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"ERIN\", \"nickname\": null, \"middle_name\": \"BOOK\", \"last_name\": \"MULLEN\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 61426, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"CHERYL\", \"nickname\": null, \"middle_name\": \"LYNN\", \"last_name\": \"JAEGER\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}], \"conviction_disclosures\": [], \"foreign_entities\": [], \"affiliated_organizations\": []}"]], "columns": ["filing_uuid", "filing_type", "registrant_id", "registrant_name", "client_id", "client_name", "filing_year", "filing_period", "received_date", "amount_reported", "is_amendment", "is_no_activity", "is_termination", "raw_json"], "primary_keys": ["filing_uuid"], "primary_key_values": ["0ae8782a-e4e9-4bc3-bcdd-ab34c71ec19d"], "units": {}, "query_ms": 46.6267520096153, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}